REFERENCES
- Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004;44:248–252.
- Xu SP, Touyz RM. Reactive oxygen species and vascular remodelling in hypertension: Still alive. Canadian Journal of Cardiology 2006;22:947–951.
- Edelson GW, Sowers JR. Insulin resistance in hypertension: a focused review. Am J Med Sci 1993;306:345–347.
- Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci U S A 1987;84:5918–5922.
- Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043–1046.
- Baranano DE, Rao M, Ferris CD, Snyder SH. Biliverdin reductase: A major physiologic cytoprotectant. Proceedings of the National Academy of Sciences of the United States of America 2002;99:16093–16098.
- Ahmad Z, Salim M, Maines MD. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress. Journal of Biological Chemistry 2002;277:9226–9232.
- Kravets A, Hu ZB, Miralem T, Torno MD, Maines MD. Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1. Journal of Biological Chemistry 2004;279:19916–19923.
- Lerner-Marmarosh N, Shen J, Torno MD, Kravets A, Hu Z, Maines MD. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc Natl Acad Sci U S A 2005;102:7109–7114.
- Yan W, Yang X, Zheng Y, Ge D, Zhang Y, Shan Z, Simu H, Sukerobai M, Wang R. The metabolic syndrome in Uygur and Kazak populations. Diabetes Care 2005; 8:2554–2555.